相关实验视频

Updated: Jun 6, 2025

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

基于机制的方法在设计针对无意义突变疾病的患者特异组合疗法时

Saleem Bhat¹, Arpan Bhattacharya^1,2, Hong Li¹

¹Department of Chemistry, University of Pennsylvania, Philadelphia, PA 19104, USA.

bioRxiv : the preprint server for biology

|November 28, 2024

概括

过早终结子 (PTC) 疾病是由无意义突变引起的. 了解停止代码的背景解释了为什么阿塔卢伦在治疗这些遗传疾病的有效性有所不同.

科学领域:

分子生物学分子生物学
遗传学是一个遗传学.
药理学药理学是指药理学的学科.

背景情况:

过早终结子 (PTC) 疾病是由无意义突变引起的,占人类疾病突变的12%.
目前对PTC阅读的治疗方法有限,尽管毒性低,但阿塔卢伦的疗效不一致.
停止密码子身份和mRNA序列上下文显著影响PTC读透效率.

研究的目的:

调查PTC身份和mRNA序列上下文如何调节翻译终结.
阐明阿塔卢伦在刺激PTC阅读过程中的可变有效性的机制.
为了确定预测患者对阿塔卢伦治疗反应的因素.

主要方法:

在测试中使用了体外复制系统 (PURE-LITE).
采用集体和单分子试验来研究翻译终结.
研究了释放因子复合体 (RFC) 和PTC在不同序列环境中的相互作用.

主要成果:

PTC 标识和相邻的 mRNA 序列调节释放因子复合体 (RFC) 的催化活性.
这种调制直接影响阿塔卢伦在刺激PTC读透中的效率.
阿塔鲁伦的有效性取决于RFC相互作用的强度,这取决于PTC序列上下文.

结论:

一个PTC的序列上下文是阿塔卢伦治疗疗效的关键决定因素.
具有强烈RFC相互作用的PTC患者预计会对阿塔卢伦耐药.
预计阿塔鲁伦在PTC序列赋予较弱RFC相互作用的患者中更有效,这解释了临床变异性.

更多相关视频

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

A Strategy to Identify de Novo Mutations in Common Disorders such as Autism and Schizophrenia

Published on: June 15, 2011

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Engineering Oncogenic Heterozygous Gain-of-Function Mutations in Human Hematopoietic Stem and Progenitor Cells

Published on: March 10, 2023

相关概念视频

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...

Nonsense-mediated mRNA Decay

Nonsense-mediated mRNA Decay

The Upf proteins that carry out nonsense-mediated decay (NMD) are found in all eukaryotic organisms, including humans. Each protein has an individual role, but they need to work in collaboration. Upf1 is an ATP-dependent RNA helicase that unwinds the RNA helix. Because Upf1 can unwind any RNA, Upf2 and Upf3 are required to help Upf1 discriminate between nonsense and normal mRNAs.
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...

Mismatch Repair

Mismatch Repair

Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...

Gene Therapy

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...